We are live on ! Find out more
NNVC icon

NanoViricides

37 hedge funds and large institutions have $1.74M invested in NanoViricides in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

5,100% more call options, than puts

Call options by funds: $104K | Put options by funds: $2K

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

3% more funds holding

Funds holding: 3637 (+1)

0.66% less ownership

Funds ownership: 10.16%9.5% (-0.66%)

17% less capital invested

Capital invested by funds: $2.09M → $1.74M (-$349K)

Holders
37
Holders Change
+1
Holders Change %
+2.78%
% of All Funds
0.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
7
Reduced
5
Closed
2
Calls
$104K
Puts
$2K
Net Calls
+$102K
Net Calls Change
+$33K

NNVC Hedge Fund Activity: Q1 2025 in Review

37 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q1 2025, worth a combined $1.74M — down 17% from $2.09M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NNVC positions and 2 closed out — a net gain of 1 holder — while 7 added to existing stakes and 5 trimmed.

The largest buyer was XTX Topco, opening a new position worth an estimated $65K. The largest seller was Renaissance Technologies, cutting an estimated $50.6K.

  • 37 institutional investors held NanoViricides (NNVC) as of Q1 2025, up from 36 in Q4 2024.
  • Funds reported $1.74M of NanoViricides stock for Q1 2025, down 17% quarter-over-quarter.
  • 3 funds opened new NanoViricides positions in Q1 2025 and 2 closed out, a net change of +1 holder.
  • The largest NanoViricides buyer in Q1 2025 was XTX Topco, an estimated $65K added.
  • The largest NanoViricides seller in Q1 2025 was Renaissance Technologies, an estimated $50.6K sold.

Based on aggregated 13F filings for Q1 2025.